KOR

e-Article

514 POSTER A novel dosing strategy based on plasma levels of CanAg in a Phase II study of IMGN242 (HUC242-DM4) in gastric cancer
Document Type
Abstract
Source
In EJC Supplements 2008 6(12):163-163
Subject
Abstracts
Language
ISSN
1359-6349